Loading provider…
Loading provider…
Hematology & Oncology Physician in Cleveland, OH
NPI: 1366406456Primary Practice Location
CLEVELAND CLINIC
9500 Euclid Ave, Cleveland, OH
Primary Employer
Cleveland Clinic
clevelandclinic.org
HQ Phone
Get MD Alan's Phone Numberphone_androidMobile
Get MD Alan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
1982 - 2026
MI State Medical License
2002 - 2021
CA State Medical License
2003 - 2020
PA State Medical License
1983 - 2016
IL State Medical License
2002 - 2005
NY State Medical License
2002 - 2005
OH State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
University Of Cincinnati College Of Medicine
med.uc.edu
Medical School
Until 1980
University of Pennsylvania Health System
Fellowship • Hematology and Medical Oncology
1983 - 1986
Case Western Reserve University/University Hospitals Cleveland Medical Center
Residency • Internal Medicine
1980 - 1983
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99212Established patient outpatient visit, total time 10-19 minutes | 179 | 313 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 62 | 63 |
| 3 | 99203New patient outpatient visit, total time 30-44 minutes | 58 | 58 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 45 | 58 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 23 | 23 |
Authors: Mohamad Hussein, Steven Andresen
Journal: Am J Clin Oncol
Thrombotic thrombocytopenic purpura: The role of ADAMTS13.
Authors: Rogers, Heesun J, Allen, Charles, Lichtin, Alan E
Journal: Cleve Clin J Med
Authors: Mikkael Sekeres
Journal: Am J Hematol
Lead Sponsor: Rigel Pharmaceuticals
Intervention / Treatment: DRUG: Fostamatinib 150 mg bid
Lead Sponsor: Principia Biopharma, a Sanofi Company
Intervention / Treatment: DRUG: Placebo, DRUG: Rilzabrutinib